• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Illinois trips over its own insurance regs

Article

News brief.

 

State Scan

Illinois trips over its own insurance regs

By Daniel B. Moskowitz, Contributing Editor

An unintended consequence of state regulators getting tougher about enforcing health insurance solvency standards is putting Illinois in a squeeze. Three insurers have been forced into liquidation by the state Department of Insurance over the past year, and their members have come knocking on the door of a state program set up 11 years ago to help those deemed commercially uninsurable. Unfortunately, the program has been having enough money troubles of its own—collecting only about 45 percent of the cost of providing care—and hasn't been able to accommodate the former customers of the liquidated companies.

After years of holding right around the 5,000 mark, enrollment surged by 10 percent in the first half of 2000. The new demand came partly from those who had been insured in the liquidated companies, but also because solvent companies have tightened underwriting guidelines and are turning down almost anyone who had ever been treated for hypertension or with asthma, explains Janet Kirby, director of underwriting for the program. In addition, those in the program are getting more expensive care. "When they become ill, they become quite ill," Kirby says. In 1999, 182 enrollees had claims of more than $50,000. Last year, the number topping that level was 238.

The program has stopped taking new members, and Gov. George Ryan is seeking a supplemental appropriation. Until it comes through, there's a waiting list, and about 15 percent of those on it were once insured by the out-of-business firms.

 



Daniel Moskowitz. Illinois trips over its own insurance regs.

Business and Health

2001;4:21.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
© 2024 MJH Life Sciences

All rights reserved.